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Abstract
Background: Primary amenorrhea due to 46,XY disorders of sex differentiation (DSD) is a frequent reason for
consultation in endocrine and gynecology clinics. Among the genetic causes of low-testosterone primary
amenorrhea due to 46,XY DSD, SRY gene is reported to be frequently involved, but other genes, such as SF1 and
WT1, have never been studied for their prevalence.
Methods: We directly sequenced SRY, SF1 and WT1 genes in 15 adolescent girls with primary amenorrhea, low
testosterone concentration, and XY karyotype, to determine the prevalence of mutations. We also analyzed the LH
receptor gene in patients with high LH and normal FSH concentrations.
Results: Among the 15 adolescents with primary amenorrhea and low testosterone concentration, we identified
two new SRY mutations, five new SF1 mutations and one new LH receptor gene mutation. Our study confirms the
10-15% prevalence of SRY mutations and shows the high prevalence (33%) of SF1 abnormalities in primary
amenorrhea due to 46,XY DSD with low plasma testosterone concentration.
Conclusions: The genetic analysis of low-testosterone primary amenorrhea is complex as several factors may be
involved. This work underlines the need to systematically analyze the SF1 sequence in girls with primary
amenorrhea due to 46,XY DSD and low testosterone, as well as in newborns with 46,XY DSD.
Background
Adolescent primary amenorrhea is a frequent reason for
consultation in pediatric and gynecological endocrine
clinics. Primary amenorrhea may result from congenital
abnormalities in gonadal or genital tract development or
from a defect in the hypothalamic-pituitary-ovarian axis.
Failure to menstruate by the age of 15 years requires
investigation to determine the cause and establish a treat-
ment plan. The standard investigation includes detailed
clinical evaluation [1], endocrine assessment (gonadotro-
pins, testosterone, AMH and inhibin B assays) and pelvic
imaging. In addition, genetic exploration is crucial to
classify the primary amenorrhea. Karyotyping, which dis-
criminates normal from abnormal chromosomes (i.e., 45,
X0 or 46,XY), is the first step. In the 46,XY disorders of
sex differentiation (DSD) [2], primary amenorrhea may
be caused by a genetic defect in fetal testis determination,
failure of the fetal testis to produce testosterone, or
androgen resistance [3]. The assessment of endocrine
parameters thus often orients the exploration toward the
most probable genetic cause [4]. For example, when
plasma testosterone (pl-T) is low, an abnormality in the
genes involved in fetal testis determination, such as SRY,
SF1, WT1, SOX9, DMRT, DHH, DAX1 and WNT4,
should be considered [5].
Here we describe a two-year experience of genetic
exploration in adolescents with primary amenorrhea due
to 46,XY DSD and low pl-T concentration. We specifically
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previously been reported to be implicated in adolescents
presenting with primary amenorrhea due to 46,XY DSD in
association with low pl-T, but no other signs. Our aim was
thus to assess the frequency of mutations in these genes in
a cohort of 15 adolescents with this profile. We identified
eight unreported mutations in these genes responsible for
testis differentiation and development: two new mutations
in SRY and five new mutations in SF1.M o r e o v e r ,i na
patient with a specific biological profile of elevated LH and
normal FSH concentrations, we identified a new LH recep-
tor mutation. Thus far, we have been unable to determine
a genetic cause for the primary amenorrhea in the seven
remaining subjects.
Methods
Patient cohorts
Over a two-year period (2007-2009), we studied 31 ado-
lescent patients with primary amenorrhea due to 46,XY
DSD who had been referred by collaborating centers to
the gynecological unit of our pediatric endocrine clinic
or to our genetics laboratory. All patients had a 46,XY
karyotype. We were able to classify these adolescents
with primary amenorrhea into two main groups. The
first group was composed of 16 patients with high pl-T
concentrations, whereas the second group comprised 15
patients with low pl-T (< 0.4 ng/ml) and elevated gona-
dotropins (Table 1). We focused our study on the sec-
ond group. The phenotype of most of these patients was
female and 5/15 of them presented with isolated clitoro-
megaly (Table 1).
Mutation analysis
With the informed consent of the patients and/or their
parents, DNA was extracted from peripheral blood leu-
kocytes. The study was approved by the institutional
review boards of all collaborating hospitals. The entire
coding region and splice sites of the SRY, NR5A1 (SF1)
and Wilm’st u m o r( WT1) genes were PCR-amplified
using previously described primers and conditions [6-8]
Table 1 Clinical, endocrine and genetic features of the 15 adolescents with primary amenorrhea and low testosterone
External
genitalia
Tanner
stages
Uterus Gonads pathology T
(ng/ml)
FSH
(UI/l)
LH
(UI/l)
Mutation Inheritance Protein
consequences
Patient
1
Normal female B3P3 Present Streak gonads 0.66 33 9.4 SRY:
c.292T>C
Hemizygous p.Trp98Arg
Patient
2
Normal female ND Present ND < 0.1 13 2 SRY:
c.319insA
Hemizygous p.
Trp107MetfsX21
Patient
3
Normal female ND ND ND < 0.1 ND ND SF1:
c.1A>G
Heterozygous p.Met1Val
(probably p.0)
Patient
4
Clitoromegaly ND ND Gonads in labia < 0.1 ND ND SF1:
c.116G>C
Heterozygous p.Arg39Pro
Patient
5
Clitoromegaly ND ND Testicular tissue/inguinal region 0.7 ND ND SF1:
c.151delG
Heterozygous p.
Glu51ArgfsX23
Patient
6
Clitoromegaly
+ Virilization
ND ND ND 2,2
(post
HCG)
ND ND SF1:
c.369insC
Heterozygous p.
Pro124ProfsX24
Patient
7
Normal female B1A2P5 Present ND 0.3 40 18 SF1:
c.1138G>T
Heterozygous p.Asp380Tyr
Patient
8
Normal female B1A3P3 ND Presence of Sertoli cells 0.33 8.7 11.2 LHCGR:
c.1395G>A
Homozygous p.Trp465X
Patient
9
Normal female ND Absent Streak gonads 0.35 102 28 None - -
Patient
10
Normal female B1P1 ND ND 0.38 135 42 None - -
Patient
11
Clitoromegaly
+ Hirsutism
ND Present Gonadoblastoma 0.3 ND ND None - -
Patient
12
Normal female ND Present Streak gonads < 0.1 78 46 None - -
Patient
13
Normal female ND ND Gonadal dysgenesis < 0.1 59 45.8 None - -
Patient
14
clitoris and
labia agenesis
B2P4 Present Left dysgerminoma, Right
fibrous structure (few tubules)
0.14 71.7 18.6 None - -
Patient
15
Clitoromegaly B1P4 Absent ND 0.3 56.3 29.5 None - -
Normal ranges: basal T, 0.35-0.9 ng/ml; FSH, 1-12 UI/l; LH, 1-5 UI/l. Conversion to SI: T ng/ml × 3,47 for nmol/l.
ND: Not Determined
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(Applied Biosystems) and an ABI Prism 3130 genetic
analyzer (Applied Biosystems).
Predicted SRY and SF1 mutation effects
Amino acid substitutions were studied in silico to pre-
dict the effects. We performed the in silico analysis
using two software packages, PolyPhen [9] and SIFT
[10]. The PolyPhen algorithm is able to predict the
functional effects of amino acid changes by considering
evolutionary conservation, physicochemical differences,
and the proximity of the substitution to predicted func-
tional domains and/or structural features. The SIFT
algorithm predicts the functional importance of amino
acid substitutions based on the alignment of orthologous
and/or paralogous protein sequences. Scores lower than
0.05 suggest the potential pathogenicity of mutations.
The original protein sequences were obtained from the
Ensembl and UniProt/Swiss-Prot databases.
Results
Mutation analysis
Direct sequencing of SRY revealed two new mutations
in patients 1 and 2 (Table 1). Patient 1 showed a variant,
c.292T>C, leading to the amino acid p.Trp98Arg substi-
tution in a highly conserved HMG domain (Figure 1).
This variant was absent in 100 control chromosomes. In
patient 2, we identified a new nucleotide insertion in
SRY (c.319insA). This insertion led to a premature stop
codon 21 amino acids after the mutated codon in the
DNA binding domain, which doubtlessly abolished the
SRY function.
When the SRY sequence was normal, we systemati-
cally studied the SF1 and WT1 sequences. We identified
five new heterozygous SF1 mutations in patients 3, 4, 5,
6 and 7 (Table 1). Among them, three were nucleotide
substitutions: c.1A>G (p.Met1Val) for patient 3,
c.116G>C (p.Arg39Pro) for patient 4, and c.1138G>T
(p.Asp380Tyr) for patient 7. The two other SF1 muta-
tions were a deletion, c.151delG, for patient 5 and an
insertion, c.369insC, for patient 6 (Figure 2). These
mutations led to a frame shift with a premature stop
codon 23 and 24 amino acids later, respectively. Proteins
resulting from these mutations are predicted to have
null activity. No mutation of WT1 was identified in our
group.
As patient 8 had elevated LH and normal FSH con-
centrations (Table 1), we performed LHCGR analysis.
The direct sequencing of this gene revealed a new
homozygous LH receptor mutation, c.1395G>A
(p.Trp465X), leading to a stop codon that causes an
aberrant transmembrane domain (Figure 3). As most of
the transmembrane domain was missing, it was certain
that the LH receptor was non-functional.
Prediction of missense mutation effects
We used two software packages to predict the functional
effects of the amino acid substitutions. First, we per-
formed testing with PolyPhen [11]. Except for the mis-
sense mutation affecting the initiating codon, all
missense substitutions were classed as “probably
damaging”.
The same assessment was performed with SIFT [12].
Similar to the PolyPhen method, the SIFT score for
these SRY and SF1 substitutions was 0.00, except for
p.Met1Val, which cannot be predicted by this software.
This score placed the missense mutations in the “Affects
protein function” class and confirmed the evaluation by
the PolyPhen algorithm.
The other mutations were an insertion and a deletion,
and the prediction software was unable to assess their
deleterious effects. However, these mutations lead
rapidly to premature stop codons and truncated pro-
teins, with probably altered function. For the LH
Figure 1 Representation of SRY gene (A) and protein (B) showing the localization of mutations identified in adolescents with primary
amenorrhea due to 46,XY DSD.
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was not necessary since the amino acid substitution
leads to a stop codon within the transmembrane domain
and results in a protein with no intracellular domain.
Discussion
Primary amenorrhea is a frequent reason for consulta-
tion in pediatric endocrine and gynecology clinics.
Three types of primary amenorrhea can be observed: (1)
46,XX amenorrhea with high FSH concentration, which
usually corresponds to a reduction in the number of pri-
mary follicles, accelerated follicular atresia, or follicular
dysfunction; (2) 45,X0 amenorrhea associated with
Turner syndrome; and (3) amenorrhea due to 46,XY
DSD. This last can be further classified into two sub-
types. The first is defined by primary amenorrhea with
normal or high testosterone concentration, suggesting
androgen insensitivity syndrome or possibly 5-alpha
reductase type 2 deficiency. The second is defined by
primary amenorrhea with low testosterone concentra-
tion. The etiologies are multiple and testis determina-
tion genes such as SRY, SF1 or WT1 should be explored.
In our 31 adolescents with primary amenorrhea due to
46,XY DSD, 16 showed high testosterone concentrations
and, as expected, AR gene mutation was a major cause
among those who presented with breast development
(B5) contrasting with an absence of pubic hair (P1)
(data not presented). For the group with low testoster-
one concentration and considered as 46,XY gonadal dys-
genesis [13], we systematically analyzed SRY, SF1 and
WT1 genes, beginning with SRY. Gene analysis identi-
fied two new SRY mutations (2/15). This frequency
(13.3%) is similar to that usually reported in the litera-
ture, which varies from 10 to 15% [14], and suggests
Figure 3 Representation of LHCGR gene (A) and protein (B) showing the localization of mutations identified in adolescents with
primary amenorrhea due to 46,XY DSD.
Figure 2 Representation of SF1 gene (A) and protein (B) showing the localization of mutations identified in adolescents with primary
amenorrhea due to 46,XY DSD.
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adolescents with primary amenorrhea due to 46,XY
DSD and low pl-T.
Patients without SRY gene mutations were analyzed
for defects in WT1 or SF1. WT1 is normally associated
with Frasier or Denys-Drash syndrome. In our experi-
ence with this gene analysis, we have identified a muta-
tion three times in patients with no sign of kidney
abnormality or cancer (unpublished). However, no cases
of WT1 abnormality were noted in the present study
group.
In contrast, we identified five new SF1 mutations in
this cohort (5/15), which amounts to one third of the
cases of primary amenorrhea due to 46,XY DSD with
low pl-T level and 5/31 of the cases of primary amenor-
rhea due to 46,XY DSD. Among these new mutations,
three nucleotide substitutions, one insertion and one
deletion were identified.
Although in vitro studies are needed to demonstrate
the implication of these mutations, two of our SF1
mutations and the SRY insertion certainly abolished
activity since an insertion or deletion creates a frame
shift and premature stop codon. The p.M1V SF1 mutant
probably abolished the transcriptional initiation. An
alternative initiation codon is located downstream at
codon 78, after the DNA-binding domain, and probably
altered the SF1 function. A similar mutation in the
initiation codon (p.Met1Ile) was reported in a girl with
hypertrophic clitoris, which confirms the impact of this
abnormality [15]. These three cases are similar to the
cases of haploinsufficiencyr e p o r t e db yo u rg r o u pa n d
others [16-18] in patients with complete sex reversal.
For the two other SF1 missense mutations and the SRY
substitution reported here, the functional effects pre-
dicted by the two types of software were concordant,
w i t ht h es a m ec o n c l u s i o no fa ffected protein mutants.
These predictions agreed with the phenotype and hor-
monal data observed in our patients, and we can con-
clude that these mutations were probably the cause of
the phenotype and the biological abnormalities.
We analyzed the LH receptor gene in one of the girls
of our cohort because of high LH contrasting with nor-
mal FSH concentration [19]. We were thus able to iden-
tify a previously unreported LHCGR mutation leading to
an inactive truncated LH receptor.
For the seven primary amenorrhea adolescents with
low pl-T concentrations and no mutation in any of the
studied genes, it is probable that one of the other genes
implicated in DSD was mutated. The absence of asso-
ciated signs was a supplementary difficulty for the orien-
tation of genetic exploration, but further gene analysis is
warranted to identify the etiology of the DSD observed
in these patients. Any one of several genes could be
involved, such as SOX9, DMRT,o rDHH,a sw e l la s
duplications of DAX1 or WNT4. However, these genes
are not often found to be mutated, especially without
specific associated signs.
Conclusions
To conclude, the genetic analysis of low-testosterone
primary amenorrhea due to 46,XY DSD is complex
since several factors may be involved, including SRY,
SF1, WT1 and LH receptor. We confirmed that SRY
was mutated in about 10 to 15% of the cases. More
interestingly, we identified new SF1 mutations in five of
our 15 patients. As this amounts to one third of our
cohort, we suggest that the SF1 sequence should be sys-
tematically analyzed in girls with primary amenorrhea
due to 46,XY DSD and low testosterone concentration,
as well as in newborns with 46,XY DSD.
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